Jonathan Graham

Track

Insider profile

Currently holds a position at Amgen Inc

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 30% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President, General Counsel, Secretary Amgen Inc July 1, 2015 -
Senior Vice President, General Counsel Danaher Corp July 1, 2006 - Nov. 24, 2015
Jonathan Graham's trades of Amgen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Amgen Inc (AMGN)
Transaction date
Sale
Price
182.27
Quantity 28,088 +6.8%
Value US$1,603,199
US Amgen Inc (AMGN)
Transaction date
Proposed sale
Price
432.57
Quantity 54,913
Value US$1,975,229
US Amgen Inc (AMGN)
Transaction date
Sale
Price
399.87
Quantity 94,574 -29.3%
Value US$3,609,135
US Amgen Inc (AMGN)
Transaction date
Proposed sale
Price
272.83
Quantity 10,000
Value US$2,728,300
US Amgen Inc (AMGN)
Transaction date
Sale
Price
241.81
Quantity 13,500 -26.6%
Value US$3,264,454
US Amgen Inc (AMGN)
Transaction date
Sale
Price
236.51
Quantity 11,110 -21.8%
Value US$2,627,625
US Amgen Inc (AMGN)
Transaction date
Sale
Price
230.54
Quantity 9,000 -17.4%
Value US$2,074,837
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-10 2025-02-07
US Amgen Inc (AMGN)
S Sale
28,088 +6.8%
182.27
US$1,603,199 		28,088 +6.8% 182.27 US$1,603,199
2025-02-07 2025-02-07
US Amgen Inc (AMGN)
PrS Proposed sale
54,913
432.57
US$1,975,229 		54,913 432.57 US$1,975,229
2023-11-13 2023-11-08
US Amgen Inc (AMGN)
S Sale
94,574 -29.3%
399.87
US$3,609,135 		94,574 -29.3% 399.87 US$3,609,135
2023-11-08 2023-11-08
US Amgen Inc (AMGN)
PrS Proposed sale
10,000
272.83
US$2,728,300 		10,000 272.83 US$2,728,300
2022-05-10 2022-05-10
US Amgen Inc (AMGN)
S Sale
13,500 -26.6%
241.81
US$3,264,454 		13,500 -26.6% 241.81 US$3,264,454
2021-02-05 2021-02-04
US Amgen Inc (AMGN)
S Sale
11,110 -21.8%
236.51
US$2,627,625 		11,110 -21.8% 236.51 US$2,627,625
2019-11-25 2019-11-22
US Amgen Inc (AMGN)
S Sale
9,000 -17.4%
230.54
US$2,074,837 		9,000 -17.4% 230.54 US$2,074,837